REFERENCES
1. Xiao-Wu W, Herndon DN, Spies M, Sanford AP, Wolf SE. Effects of delayed wound excision and grafting in severely burned children. Arch Surg 2002;137:1049-54.
2. Janzekovic Z. A new concept in the early excision and immediate grafting of burns. J Trauma 1970;10:1103-8.
3. Gravante G, Delogu D, Esposito G, Montone A. Versajet hydrosurgery versus classic escharectomy for burn débridment: a prospective randomized trial. J Burn Care Res 2007;28:720-4.
4. Rosenberg L, Lapid O, Bogdanov-Berezovsky A, Glesinger R, Krieger Y, Silberstein E, Sagi A, Judkins K, Singer AJ. Safety and efficacy of a proteolytic enzyme for enzymatic burn débridement: a preliminary report. Burns 2004;30:843-50.
5. Rosenberg L, Krieger Y, Bogdanov-Berezovski A, Silberstein E, Shoham Y, Singer AJ. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT. Burns 2014;40:466-74.
6. Krieger Y, Bogdanov-Berezovsky A, Gurfinkel R, Silberstein E, Sagi A, Rosenberg L. Efficacy of enzymatic debridement of deeply burned hands. Burns 2012;38:108-12.
7. Cordts T, Horter J, Vogelpohl J, Kremer T, Kneser U, Hernekamp J. Enzymatic debridement for the treatment of severely burned upper extremities - early single center experiences. BMC Dermatol 2016;16:8.
8. Schulz A, Shoham Y, Rosenberg L, Rothermund I, Perbix W, Christian Fuchs P, Lipensky A, Schiefer JL. Enzymatic versus traditional surgical debridement of severely burned hands: a comparison of selectivity, efficacy, healing time, and three-month scar quality. J Burn Care Res 2017;38:e745-55.
9. Schulz A, Fuchs PC, Rothermundt I, Hoffmann A, Rosenberg L, Shoham Y, Oberländer H, Schiefer J. Enzymatic debridement of deeply burned faces: healing and early scarring based on tissue preservation compared to traditional surgical debridement. Burns 2017;43:1233-43.
10. Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez JR, Monstrey S, Murray A, Plock JA, Sander F, Schulz A, Ziegler B, Kneser U. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: an european consensus. Burns 2017;43:1640-53.
11. Krieger Y, Rosenberg L, Lapid O, Glesinger R, Bogdanov-berezovsky A, Silberstein E, Sagi A, Judkins K. Escharotomy using an enzymatic debridement agent for treating experimental burn-induced compartment syndrome in an animal model. J Trauma 2005;58:1259-64.
12. Schulze SM, Weeks D, Choo J, Cooney D, Moore AL, Sebens M, Neumeister MW, Wilhelmi BJ. Amputation following hand escharotomy in patients with burn injury. Eplasty 2016;16:e13.
13. Kern MA, Depka von N, Schackert C, Henkel W, Hirche CR. Enzymatic burn wound debridement with NexoBrid®: cost simulations and investigations on cost efficiency. Gesundheitsökonomie Qual 2018;23:21-8.
14. Schulz A, Perbix W, Shoham Y, Daali S, Charalampaki C, Fuchs PC, Schiefer J. Our initial learning curve in the enzymatic debridement of severely burned hands-management and pit falls of initial treatments and our development of a post debridement wound treatment algorithm. Burns 2017;43:326-36.
15. Jaeger M, Harats M, Kornhaber R, Aviv U, Zerach A, Haik J. Treatment of hypergranulation tissue in burn wounds with topical steroid dressings: a case series. Int Med Case Rep J 2016;9:241-5.
16. Loo YL, Goh BKL, Jeffery S. An overview of the use of bromelain-based enzymatic debridement (Nexobrid®) in deep partial & full thickness burns: appraising the evidence. J Burn Care Res 2018; doi: 10.1093/jbcr/iry009.
17. Osinga R, Steiger P, Giovanoli P, Plock JA, Mannil L. Burn wound treatment through enzymatic debridement: first experience in Switzerland. Handchir Mikrochir Plast Chir 2018; doi: 10.1055/s-0044-100613.
18. Edmondson SJ, Jumabhoy IA, Murray A. Is it time to start putting down the knife? a systematic review of burns debridement tools of randomised and non-randomised trials. Burns 2018; doi: 10.1016/j.burns.2018.01.012.
